Strategy & M&A Manager
Dexa Group
Pelamar Masih Sedikit- Penuh waktu
- On-site • Tangerang Selatan
- Negotiable
Deskripsi Pekerjaan
- Identify new international markets strategy for expansion
- Conduct market entry assessments (market size, competitor landscape, regulatory barriers)
- Develop go-to-market strategies tailored for each region
- Work with internal R&D and Regulatory Affairs to select products suitable for international markets
- Drive commercialization strategies (product positioning, pricing, channel management)
- Support due diligence activities and assist in integration plans post-transaction
Kualifikasi
- Must possess at least Bachelor's Degree in Finance
- Minimum of 3 years of experience Experience in business development or commercial strategy, preferably within the healthcare, pharmaceutical, or life sciences sectors
- Solid understanding of the pharmaceutical industry is a strong advantage
- Prior M&A exposure or experience is a plus
- Prior Big4 experience is a plus
- Placement: HO Bintaro, Tangerang Selatan
Tips Menjaga Diri
Perusahaan dan Lowongan di Dealls tidak meminta data pribadi, informasi rekening, atau pungutan ketika melamar. Hindari juga lowongan Google Form / Grup Telegram tanpa keabsahan yang jelas.
Dexa Group has evolved from a small company established in 1969 to one of Indonesia’s largest ethical pharmaceutical companies at the beginning of the 21st century and has become a prominent, well-respected player in the domestic pharmaceutical market.
Providing better health care by applying expertise was the foundation on which its founders built this Company. Honesty, trust, dedication and commitment to providing patients with the highest quality of ethical pharmaceutical products and OTC are preserved as the guiding principles, based upon which the highly professional management team and the motivated, competent staff of Dexa Group have developed the Company in the spirit of mutual respect, teamwork and innovation over more than four decades.
Serving as a good corporate citizen is one of our responsibilities and being a strategic asset of Indonesia is one of our foremost desires. For along time Dexa Group has worked together with governing institutions and the Indonesian Pharmaceutical Association – championing compliance and improving the industry standards.
Ir. Ferry A. Soetikno, M.Sc., M.B.A.
(President Director)
